CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | White William Richard Director | Sale 10b5-1 | −162 | $28.52 | $5K | 39 |
| 2024-05-01 | White William Richard Director | Sale 10b5-1 | −39 | $29.11 | $1K | 0 |
| 2024-05-01 | White William Richard Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −201 | 3,211 | ||
| 2024-04-11 | White William Richard Director | Option exercise 10b5-1 | +1,756 | $2.65 | $5K | 1,756 |
| 2024-04-11 | White William Richard Director | Option exercise 10b5-1 | +804 | $9.86 | $8K | 2,560 |
| 2024-04-11 | White William Richard Director | Sale 10b5-1 | −2,482 | $31.79 | $79K | 78 |
| 2024-04-11 | White William Richard Director | Sale 10b5-1 | −78 | $32.18 | $3K | 0 |
| 2024-04-11 | White William Richard Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,756 | 5,268 | ||
| 2024-04-11 | White William Richard Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −804 | 3,412 | ||
| 2024-04-10 | Savage William Jacob Chief Medical Officer | Option exercise | +21,870 | $2.65 | $58K | 43,405 |
| 2024-04-10 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −13,093 | 4,233 | ||
| 2024-04-10 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −8,777 | 1,498 | ||
| 2024-03-05 | Bitterman Kevin Director | Sale | −26,157 | $73.50 | $1.9M | 677,503 |
| 2024-02-26 | Stephenson Pamela Chief Commercial Officer | Grant or award | +36,666 | 36,666 | ||
| 2024-02-26 | Stephenson Pamela Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2024-02-07 | Franchi Jean M. Chief Financial Officer | Grant or award | +36,666 | 36,666 | ||
| 2024-02-07 | Franchi Jean M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2024-01-23 | Bitterman Kevin Director | Sale | −82,500 | $67.65 | $5.6M | 703,660 |
| 2024-01-23 | Bitterman Kevin Director | Sale | −20,000 | $67.65 | $1.4M | 198,326 |
| 2024-01-23 | Atlas Venture Fund X, L.P. 10% owner | Sale | −47,500 | $67.65 | $3.2M | 1,402,186 |
Page 22 of 32 · 639 trades